ClinConnect ClinConnect Logo
Search / Trial NCT00857610

Retinol-induced Dermatitis in Aged Skin

Launched by UNIVERSITY OF MICHIGAN · Mar 5, 2009

Trial Information

Current as of May 24, 2025

Completed

Keywords

Aged Skin Photoaged Skin Retinol Topical Retinoids

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Male or female
  • Subject is at least 21 years of age
  • Good general health
  • No disease states, physical conditions or medications that would impair evaluation of the test sites
  • Willingness and ability to follow protocol
  • Signed written and witnessed informed consent form
  • No use of oral retnoids in the past year
  • No use of topical steroids to the treatment area in the past 2 weeks
  • Exclusion Criteria:
  • Has received an experimental drug or used and experimental device in the 14 days prior to admission to the study
  • History of keloids
  • History of hypersensitivity to lidocaine or epinephrine
  • Pregnant or nursing women
  • Disease states or physical condition that would impair evaluation of the test sites or compliance with the protocol
  • History of chemical peels or laser treatments to the sites evaluated

About University Of Michigan

The University of Michigan, a leading academic institution renowned for its commitment to advancing healthcare and medical research, serves as a prominent clinical trial sponsor. With a robust infrastructure that supports innovative research initiatives, the university leverages its multidisciplinary expertise to conduct a wide array of clinical trials aimed at improving patient outcomes and advancing medical knowledge. Through its state-of-the-art facilities and collaborative environment, the University of Michigan fosters partnerships between researchers, clinicians, and industry leaders, ensuring the development of cutting-edge therapies and interventions that address pressing health challenges.

Locations

Ann Arbor, Michigan, United States

Patients applied

0 patients applied

Trial Officials

Dana Sachs, MD

Principal Investigator

University of Michigan Professor of Dermatology

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials